Maxalt and Taltz drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Maxalt (rizatriptan benzoate) and Taltz (ixekizumab). Common drug interactions include infection among females.
The phase IV clinical study analyzes what interactions people have when they take Maxalt and Taltz. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.
What is Maxalt?
Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 12,754 Maxalt users. Check the latest studies of Maxalt.
What is Taltz?
Taltz has active ingredients of ixekizumab. eHealthMe is studying from 29,777 Taltz users. Check the latest studies of Taltz.
16 people who take Maxalt and Taltz together, and have interactions are studied.
What are the common drug interactions of Maxalt and Taltz, by gender? *:
female:
- Infection
- Colonoscopy
- Nasopharyngitis (inflammation of the nasopharynx)
- Pain
- Respiratory tract infection
- Cystitis (inflammation of the wall of the bladder)
- Ear infection
- Kidney infection
- Multiple allergies (allergy to multiple agents)
- Pigmentation disorder (disturbances of human skin colour)
male:
n/a
What are the common drug interactions of Maxalt and Taltz, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Injection site erythema (redness at injection site)
- Injection site induration
- Injection site pruritus (severe itching at injection site)
- Injection site reaction
40-49:
- Chills (felling of cold)
- Diarrhoea
- Injection site cellulitis (injection site inflammation)
- Pain
- Pyrexia (fever)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
50-59:
n/a
60+:
n/a
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 9 people, 56.25%
- Psoriasis (immune-mediated disease that affects the skin): 5 people, 31.25%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 12.50%
- Immune System Disorder: 2 people, 12.50%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 6.25%
* Approximation only. Some reports may have incomplete information.
Do you take Maxalt and Taltz?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Maxalt and Taltz:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Maxalt:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Taltz:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Maxalt and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Taltz and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on rizatriptan benzoate and ixekizumab (the active ingredients of Maxalt and Taltz, respectively), and Maxalt and Taltz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Atovaquone and Sirolimus - 7 seconds ago
- Could Triphasil-21 cause Weight Increased? - 31 seconds ago
- Drug interactions of Vibramycin and Prednisolone - 49 seconds ago
- Could Savella cause Suicidal Ideation? - 52 seconds ago
- Drug interactions of Amlodipine Besylate and Sudafed - a minute ago
- Drug interactions of Acetazolamide and Meclizine - a minute ago
- Could Neupogen cause Lymphoedema? - a minute ago
- Nasacort Aq vs. Periactin, side effect and effectiveness comparison - a minute ago
- Drug interactions of Sertraline Hydrochloride and Meropenem - a minute ago
- Could Diclofenac Sodium cause Ageusia? - a minute ago